Z

    Zimmer Biomet Holdings Inc (ZBH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $100.03
    -0.88 (-0.87%)

    Market Cap: $19.25B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    93%(37/40)
    Avg Surprise
    +7.42%
    Streak
    18 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.88
    Range$1.86 - $1.91
    24 analysts
    EPS Revisions
    12
    0
    7d
    10
    6
    30d
    EPS Estimate Drift
    90d ago$1.88-0.3%
    60d ago$1.88-0.3%
    30d ago$1.88-0.4%
    7d ago$1.88-0.0%
    Current$1.88
    Revenue Consensus
    $2.0B
    Range$2.0B - $2.2B
    24 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.78
    Range$2.74 - $2.82
    27 analysts
    Revenue Consensus
    $2.3B
    Range$2.3B - $2.4B
    26 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.78---
    Sep 26EST
    		-$1.88---
    Jun 26
    Reported Aug 5
    		$2.07$2.01+2.99%Beat+0.0%
    Mar 26
    Reported Apr 28
    		$2.09$1.86+12.37%Beat+15.5%
    Dec 25
    Reported Feb 10
    		$2.42$2.40+0.83%Beat+4.8%
    Sep 25
    Reported Nov 5
    		$1.90$1.88+1.06%Beat+9.2%
    Jun 25
    Reported Aug 7
    		$2.07$1.98+4.55%Beat+3.0%
    Mar 25
    Reported May 5
    		$1.81$1.77+2.26%Beat-6.7%
    Dec 24
    Reported Feb 6
    		$2.31$2.29+0.87%Beat+5.0%
    Sep 24
    Reported Oct 30
    		$1.74$1.74+0.00%Beat+5.5%
    Jun 24
    Reported Aug 7
    		$2.01$1.99+1.00%Beat+10.4%
    Mar 24
    Reported May 2
    		$1.94$1.87+3.74%Beat+2.6%
    Dec 23
    Reported Feb 8
    		$2.20$2.16+1.85%Beat+17.0%
    Sep 23
    Reported Nov 7
    		$1.65$1.60+3.13%Beat+4.4%
    Jun 23
    Reported Aug 1
    		$1.82$1.81+0.55%Beat+0.0%
    Mar 23
    Reported May 2
    		$1.89$1.64+15.24%Beat+17.4%
    Dec 22
    Reported Feb 3
    		$1.88$1.83+2.73%Beat-3.6%
    Sep 22
    Reported Nov 2
    		$1.58$1.56+1.28%Beat-12.7%
    Jun 22
    Reported Aug 2
    		$1.82$1.64+10.98%Beat-4.2%
    Mar 22
    Reported May 3
    		$1.61$1.42+13.38%Beat-5.8%
    Dec 21
    Reported Feb 7
    		$1.95$1.98-1.52%Miss-7.6%
    Sep 21
    Reported Nov 4
    		$1.81$1.76+2.84%Beat+0.0%
    Jun 21
    Reported Aug 3
    		$1.90$1.86+2.15%Beat+3700.0%
    Mar 21
    Reported May 4
    		$1.71$1.53+11.76%Beat+0.6%
    Dec 20
    Reported Feb 5
    		$2.11$2.06+2.43%Beat-8.3%
    Sep 20
    Reported Nov 6
    		$1.81$1.08+67.59%Beat+2.3%
    Jun 20
    Reported Aug 4
    		$0.05N/A+107.94%Beat-97.4%
    Mar 20
    Reported May 11
    		$1.70$1.47+15.65%Beat-9.1%
    Dec 19
    Reported Feb 4
    		$2.30$2.27+1.32%Beat+5.5%
    Sep 19
    Reported Nov 5
    		$1.77$1.75+1.14%Beat+8.6%
    Jun 19
    Reported Jul 26
    		$1.93$1.91+1.05%Beat+0.5%
    Mar 19
    Reported Apr 26
    		$1.87$1.86+0.54%Beat-2.1%
    Dec 18
    Reported Feb 1
    		$2.18$2.17+0.46%Beat+3.8%
    Sep 18
    Reported Oct 26
    		$1.63$1.60+1.88%Beat-5.2%
    Jun 18
    Reported Jul 27
    		$1.92$1.89+1.59%Beat-7.7%
    Mar 18
    Reported Apr 26
    		$1.91$1.89+1.06%Beat-10.3%
    Dec 17
    Reported Jan 30
    		$2.10$2.10+0.00%Beat-1.9%
    Sep 17
    Reported Nov 1
    		$1.72$1.74-1.15%Miss-3.9%
    Jun 17
    Reported Jul 27
    		$2.08$2.10-0.95%Miss-
    Mar 17
    Reported Apr 27
    		$2.13$2.11+0.95%Beat-
    Dec 16
    Reported Jan 31
    		$2.14$2.11+1.42%Beat-
    Sep 16
    Reported Oct 31
    		$1.79$1.79+0.00%Beat-

    Dividends

    Dividend Metrics

    Yield0.96%
    Annual/Share$0.96
    Payout Ratio10.58%
    Frequency4
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR+0.00%
    5Y CAGR+0.00%
    View ZBH's full dividend history

    Key Metrics

    Valuation
    P/E Ratio11.80EV/EBITDA11.17x
    Price/FCF12.62xFCF Yield7.92%
    Profitability
    Profit Margin9.48%Operating Margin18.00%
    ROE6.41%ROIC5.26%
    Financial Health
    Debt/Equity0.59xInterest Coverage4.23x
    Current Ratio1.69xQuick Ratio0.94x
    Trading Statistics
    Beta0.46Avg Volume2.14M
    52-Week High$106.0352-Week Low$78.91

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$100.29
    SMA 20$99.09
    SMA 50$94.12
    SMA 200$90.85
    EMA 10$100.01
    EMA 20$98.74
    EMA 50$95.23
    EMA 200$92.51

    MACD

    Line: 1.90Signal: 2.12Hist: -0.22

    ADX

    ADX: 22.7+DI: 24.4-DI: 14.6

    Aroon & PSAR

    Aroon Up80.0
    Aroon DownN/A
    PSAR$98.67

    Bollinger Bands

    Upper Band$102.42
    Lower Band$95.77
    %B Position671%(Upper)
    Band Width0.64

    RSI (14-Day)

    Neutral
    56.3

    Momentum Oscillators

    Stoch %K74.7
    Stoch %D77.6
    Williams %R-26.7
    ROC (10d)1.9%
    Momentum1.83
    CCI (20d)46.6
    MFI (14d)56.9

    Volatility Measures

    ATR (14d)$2.58(2.6%)
    StdDev (20d)1.66
    Hist Vol22.9%(Moderate)

    Volume Flow

    VWAP$99.95
    OBV47.2M
    AD Line-502.9M
    CMF (20d)0.157

    Volume Metrics

    Avg Vol (20d)2.1M
    Vol Ratio0.6x
    VWMA (20d)$98.58

    Pivot Points

    R3$103.81
    R2$102.57
    R1$101.74
    Pivot Point$100.49
    S1$99.66
    S2$98.42
    S3$97.59

    Advanced Oscillators

    TSI18.69
    Ultimate Osc58.2
    KST79.51

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.18B$2.09B$2.24B$2.00B$2.08B$1.91B$2.02B$1.82B$1.94B$1.89B$1.94B$1.75B
    Cost of Revenue$635.50M$576.20M$792.40M$559.30M$592.20M$549.80M$586.70M$538.60M$553.60M$512.30M$538.90M$518.60M
    Gross Profit$1.54B$1.51B$1.45B$1.44B$1.49B$1.36B$1.44B$1.29B$1.39B$1.38B$1.40B$1.24B
    Operating Expenses$1.22B$1.14B$1.30B$1.09B$1.19B$1.07B$1.05B$1.01B$1.04B$1.11B$1.05B$968.40M
    R&D$104.80M$103.40M$118.70M$115.90M$113.30M$110.60M$108.50M$111.60M$109.40M$107.90M$113.30M$116.90M
    SG&A$899.30M$849.90M$872.20M$811.40M$814.80M$758.80M$746.80M$709.70M$737.10M$736.20M$722.30M$674.90M
    Operating Income$326.10M$373.20M$154.50M$351.30M$300.00M$292.30M$389.00M$279.50M$351.30M$265.90M$354.20M$266.60M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$72.90M$68.80M$71.90M$75.40M$79.30M$66.20M$61.90M$54.30M$51.10M$50.70M$50.30M$51.10M
    Income Before Tax$255.10M$301.30M$98.00M$279.20M$224.60M$229.00M$289.00M$230.30M$302.20M$215.10M$284.50M$219.20M
    Income Tax Expense$55.50M$63.00M$-40,000,000$48.00M$71.20M$46.50M$48.90M$-18,900,000$59.10M$42.30M$-135,200,000$56.40M
    Net Income$198.30M$238.10M$139.40M$230.90M$152.80M$182.00M$239.50M$249.10M$242.80M$172.40M$418.90M$162.70M
    EBITDA$598.80M$640.20M$453.90M$638.20M$575.70M$549.60M$614.50M$535.50M$596.50M$504.40M$575.80M$511.60M
    EBIT$328.00M$370.20M$169.90M$354.60M$303.90M$295.20M$350.90M$284.60M$353.30M$265.80M$334.60M$270.40M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ZBH

    Government Contracts

    Gov Obligations (TTM)
    $13.98M
    Gov Obligations / Revenue
    0.2%
    Obligations YoY
    -36.6%
    Active Awards
    1,548
    New Awards (TTM)
    1,525
    Avg Remaining Term
    8.6 mo

    Top agency: Department of Defense at 95.6% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    SPE2D625F1UDUDepartment of DefenseDefense Logistics Agency$646224Aug 27, 2025
    FA860125P0170Department of DefenseDepartment of the Air Force$195000Sep 24, 2025
    SPE2D625F1RAWDepartment of DefenseDefense Logistics Agency$132522Aug 22, 2025
    36C26026P0348Department of Veterans AffairsDepartment of Veterans Affairs$120000Apr 1, 2026
    SPE2D626F68JBDepartment of DefenseDefense Logistics Agency$114000Feb 20, 2026
    SPE2D626F81UNDepartment of DefenseDefense Logistics Agency$110656Mar 2, 2026
    SPE2D625F1QTUDepartment of DefenseDefense Logistics Agency$99392Aug 22, 2025
    SPE2D626F514ZDepartment of DefenseDefense Logistics Agency$86731Nov 26, 2025
    75N90025P00798Department of Health and Human ServicesNational Institutes of Health$82000Sep 30, 2025
    SPE2D626F13C9Department of DefenseDefense Logistics Agency$60986Dec 9, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    NS Partners Ltd Reduces Stake in Edwards Lifesciences Corporation $EW

    NS Partners Ltd significantly reduced its stake in Edwards Lifesciences Corporation by 32.3% in the second quarter, selling over 62,000 shares. Despite this, the company reported strong quarterly earnings, exceeding analyst expectations with $0.78 EPS and a 13.6% revenue increase year-over-year. Analyst sentiment for Edwards Lifesciences remains positive, with a consensus "Moderate Buy" rating and an average price target of $100.27, although company insiders have recently sold shares.

    MarketBeat•9/1/26•
    Neutral

    Edwards Lifesciences (NYSE:EW) SVP Sells 544 Shares of Stock

    Andrew Dahl, SVP of Edwards Lifesciences (NYSE:EW), sold 544 shares of the company's stock for approximately $49,537, reducing his stake by 3.53%. This insider sale comes as Edwards Lifesciences reported strong quarterly earnings, beating EPS estimates by $0.04 and seeing revenue increase by 13.6% year-over-year. Analysts currently hold a "Moderate Buy" consensus rating for the stock, with an average price target of $100.27.

    MarketBeat•9/1/26•
    Neutral

    Zimmer Biomet declares $0.24 quarterly dividend

    Zimmer Biomet Holdings, Inc. has announced a quarterly cash dividend of $0.24 per share for the third quarter of 2026. This dividend is payable on October 30, 2026, to stockholders of record as of September 30, 2026. Zimmer Biomet is a global medical technology company with operations and sales worldwide.

    Investing.com•8/28/26•
    Bullish

    Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026

    Zimmer Biomet Holdings, Inc. announced that its Board of Directors has approved a quarterly cash dividend of $0.24 per share for the third quarter of 2026. This dividend is payable around October 30, 2026, to stockholders of record as of September 30, 2026. Zimmer Biomet is a global medical technology leader focused on improving health through innovative products and integrated digital and robotic technologies.

    PR Newswire•8/28/26•
    Somewhat-Bullish

    Zimmer Biomet Keeps Quarterly Dividend at $0.24 a Share, Payable Oct. 30 to Holders of Record Sept. 30

    Zimmer Biomet Holdings, Inc. announced it will maintain its quarterly dividend at $0.24 per share. The dividend is payable on October 30 to shareholders of record as of September 30. The article also provides recent analyst ratings and price target adjustments for Zimmer Biomet.

    marketscreener.com•8/28/26•
    Neutral

    Frequently Asked Questions About ZBH

    What is ZBH's current dividend yield?
    Zimmer Biomet Holdings Inc (ZBH) has a current dividend yield of 0.96%.
    Does ZBH pay dividends?
    Yes, Zimmer Biomet Holdings Inc pays dividends with a current yield of 0.96%.
    What is ZBH's P/E ratio?
    Zimmer Biomet Holdings Inc has a price-to-earnings (P/E) ratio of 11.80.
    What is ZBH's market cap?
    Zimmer Biomet Holdings Inc (ZBH) has a market capitalization of $19.25B with a current stock price of $100.03.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In